Here's the live share price of Curis Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Curis Lifesciences | -0.09 | 26.13 | 6.67 | -20.57 | -20.57 | -7.39 | -4.50 |
| Sun Pharmaceutical Industries | -1.38 | -5.04 | 2.32 | -1.19 | -6.65 | 19.47 | 21.14 |
| Divi's Laboratories | -0.13 | 4.52 | 4.56 | -4.26 | 6.09 | 25.33 | 10.85 |
| Torrent Pharmaceuticals | -1.72 | -3.07 | 3.88 | 13.02 | 22.57 | 36.07 | 25.96 |
| Lupin | -0.82 | 0.49 | 7.99 | 18.98 | 10.45 | 48.69 | 16.82 |
| Dr. Reddy's Laboratories | -0.36 | -2.90 | -1.51 | -4.88 | 2.61 | 8.18 | 3.19 |
| Cipla | 0.47 | 1.19 | -5.98 | -24.85 | -19.39 | 11.04 | 5.54 |
| Zydus Lifesciences | -0.98 | 8.05 | 5.43 | -7.84 | 7.13 | 21.62 | 10.97 |
| Mankind Pharma | 6.21 | 15.96 | 6.04 | -8.81 | -12.20 | 16.26 | 9.46 |
| Aurobindo Pharma | 2.50 | 11.14 | 25.49 | 29.31 | 13.99 | 34.08 | 7.43 |
| Alkem Laboratories | 1.02 | 9.38 | -2.15 | 1.68 | 7.53 | 17.95 | 15.00 |
| Glenmark Pharmaceuticals | -0.42 | 7.23 | 13.84 | 21.04 | 58.58 | 63.04 | 31.62 |
| Laurus Labs | -2.86 | 14.01 | 7.84 | 17.31 | 68.45 | 54.34 | 19.29 |
| Biocon | 2.01 | -2.55 | -2.29 | -1.24 | 6.58 | 16.61 | -2.17 |
| Abbott India | -1.70 | -0.26 | -8.50 | -15.59 | -16.57 | 4.08 | 10.97 |
| Anthem Biosciences | 4.97 | 20.81 | 24.69 | 5.77 | 3.96 | 1.30 | 0.78 |
| GlaxoSmithKline Pharmaceuticals | 1.89 | 8.18 | 6.58 | -10.69 | -13.38 | 25.48 | 11.09 |
| Ipca Laboratories | 2.29 | -2.29 | 2.19 | 17.07 | 1.62 | 21.84 | 7.32 |
| Ajanta Pharma | -1.71 | -0.63 | 2.95 | 15.10 | 3.36 | 29.24 | 17.90 |
| J B Chemicals & Pharmaceuticals | 0.14 | -4.93 | 7.14 | 15.74 | 24.74 | 23.65 | 24.22 |
Over the last one year, Curis Lifesciences has declined 20.57% compared to peers like Sun Pharmaceutical Industries (-6.65%), Divi's Laboratories (6.09%), Torrent Pharmaceuticals (22.57%). From a 5 year perspective, Curis Lifesciences has underperformed peers relative to Sun Pharmaceutical Industries (21.14%) and Divi's Laboratories (10.85%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 110.82 | 110.81 |
| 10 | 104.11 | 107.2 |
| 20 | 98.45 | 103.17 |
| 50 | 100.14 | 103.71 |
| 100 | 109.45 | 0 |
| 200 | 54.73 | 0 |
In the latest quarter, Curis Lifesciences remained same as its previous close in promoter holding, while DII stake decreased to 5.80%, FII holding fell to 1.19%, and public shareholding moved up to 24.98% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
There's no recent Announcement information to show for the company. You may visit the Curis Lifesciences fact sheet for more information
Curis Lifesciences Ltd. is a Public Limited Listed company incorporated on 23/03/2016 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is U24230GJ2016PLC086559 and registration number is 086559. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 49.13 Cr. and Equity Capital is Rs. 5.93 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Curis Lifesciences is ₹112.00 as on Apr 22, 2026.
The Curis Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the NSE.
The market cap of Curis Lifesciences is ₹90.55 Cr as on Apr 22, 2026.
Today’s highest and lowest price of Curis Lifesciences are ₹0.00 and ₹0.00.
The 52-week high/low is the highest and lowest price at which Curis Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Curis Lifesciences is ₹147.90 and 52-week low of Curis Lifesciences is ₹83.60 as on Apr 22, 2026.
The Curis Lifesciences has shown returns of 0.0% over the past day, 26.13% for the past month, 5.11% over 3 months, -20.57% over 1 year, -7.39% across 3 years, and -4.5% over 5 years.
P/E ratio of and PB ratio of Curis Lifesciences are 0.00 and 4.26 on Apr 22, 2026. While the company gives a dividend yield of 0.00 per annum.